Kirsten Svenstrup

Kirsten Svenstrup

Consultant Neurologist, PhD

Kirsten Svenstrup is a member of the MND team of Bispebjerg Hospital since 2014. She has a special interest in genetics.

Connect
Connect trials
Recruiting
Phase iii

COURAGE-ALS Trial

Industry trial

In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS. This clinical trial is sponsored by Cytokinetics.

Read more